News | December 09, 2024
AbbVie announces emotional impact report on mental health of underrepresented CLL cancer patients
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Based on data, 1.75 mg/kg dose established as recommended dose for Phase 3 trial of this investigational antibody-drug conjugate
Patients treated with Polivy in combination with R-CHP required fewer subsequent treatments, potentially reducing burdens on patients and healthcare systems
Aims to become India’s leading cancer testing company
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
For people with relapsed or refractory diffuse large B-cell lymphoma
Reaffirms Lupin’s commitment to sustainable resource management
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
